Latest in Avis’s stock slides after third quarter earnings fall short of estimates
Sort by
3,864 items
-
UnitedHealth Shares Dive After Health Giant Says 2025 Results Likely to Fall Short
The company estimates that its formal guidance for 2025 will top out at about $30 in earnings per share.Business - The Wall Street Journal - October 15 -
Novavax’s stock slides 19% after FDA puts clinical hold on COVID and flu vaccine candidates
Novavax Inc.’s stock tumbled 19% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a ...Business - MarketWatch - October 17 -
Boot Barn stock slides after CEO departure announcement, but Western-wear retailer’s forecast is more upbeat
Western-themed retail chain Boot Barn Holdings Inc. on Monday said its chief executive would be leaving next month, while forecasting better sales and profits for the full year.Business - MarketWatch - 3 days ago -
Starbucks scraps 2025 guidance after fall in sales and earnings
New chief Brian Niccol vows ‘to fundamentally change our strategy’ to return to growthBusiness - Financial Times - October 22 -
Bank of America tops estimates on better-than-expected trading revenue
Bank of America benefited from its Wall Street trading and banking divisions in the third quarter, just as rival JPMorgan Chase did.Business - CNBC - October 15 -
Ford guides to low end of 2024 earnings forecast as it slightly tops Wall Street's third-quarter expectations
Ford guides to low end of 2024 earnings forecast as it slightly tops Wall Street's Q3 expectationsBusiness - CNBC - 2 days ago -
HSBC announces fresh $3 billion share buyback as third-quarter earnings beat expectations
Pre-tax profit came in at $8.5 billion, a 10% rise from the $7.7 billion posted a year ago.Business - CNBC - 2 days ago -
Deutsche Bank warns of rising bad loan provisions
German lender posts record third-quarter profits but tells investors to brace again for credit risksBusiness - Financial Times - October 23 -
Unilever reiterates 2024 outlook after third-quarter sales growth
Unilever on Thursday reiterated its 2024 outlook after reporting underlying sales growth of 4.5% in the third quarter.Business - MarketWatch - October 24 -
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.Business - CNBC - Yesterday -
Tesla’s stock sees best day in 11 years. Why it’s still hard not to be bullish.
Tesla added $150 billion in market cap — more than the combined value of Ford, GM and Stellantis — as analysts cheered the growth forecast and increasing transparency.Business - MarketWatch - October 24 -
What to do with Honeywell stock after its sharp post-earnings pullback
The industrial giant reported mixed third-quarter results compounded by a mixed outlook.Business - CNBC - October 24 -
Amazon Stock Jumps After Earnings Report Record $15.3 Billion Profit
The tech giant’s cloud computing business picked up steam and its retail business showed resiliency.Business - The New York Times - 7 hours ago -
Deutsche Bank shares fall on doubling of third-quarter loan losses but profits rise
Deutsche Bank’s pre-tax profits were lifted by a reduction in the provisions it has set aside to settle litigation related to its Postbank acquisitionBusiness - MarketWatch - October 23 -
Starbucks CEO pledges to fundamentally change strategy as sales fall for third straight quarter
Investors are expecting that Niccol will share more details about his turnaround strategy during the company's conference call, scheduled for 5 p.m. ET.Business - CNBC - Yesterday -
Roku’s stock sinks after streaming company posts another quarterly loss
Roku Inc.’s stock fell in after-hours trade Wednesday, after the streaming platform posted another quarterly loss and flat average revenue per user.Business - MarketWatch - Yesterday -
Pfizer’s earnings crush estimates as company raises guidance
Drug company Pfizer saw strong growth for its heart-disease drugs and migraine treatment.Business - MarketWatch - 2 days ago -
Who's Stepping Up & Who's Falling Short For The Flyers
The Philadelphia Flyers have faced a challenging start to the 2024-25 NHL season, marked by a disappointing four-game losing streak, which includes a shutout loss in their home opener against the ...Sports - Yahoo Sports - October 20
